Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.
about
Mechanisms underlying skin disorders induced by EGFR inhibitorsBiomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancerRosacea: The cytokine and chemokine networkGenetic basis of irritant susceptibility in health care workersSkin problems and EGFR-tyrosine kinase inhibitorHigh-risk human papillomavirus targets crossroads in immune signalingSkin toxicities associated with epidermal growth factor receptor inhibitorsAnti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with PsoriasisNeutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptorDermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage.Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesisEGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 productionUltraviolet B radiation of human skin generates platelet-activating factor receptor agonists.Mechanisms of cutaneous toxicities to EGFR inhibitors.Plant polyphenols regulate chemokine expression and tissue repair in human keratinocytes through interaction with cytoplasmic and nuclear components of epidermal growth factor receptor system.Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers.Erlotinib-induced skin inflammation is IL-1 mediated in KC-Tie2 mice and human skin organ culture.Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung CancerAdenovirus RIDalpha regulates endosome maturation by mimicking GTP-Rab7.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin.Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy.CK2-NCoR signaling cascade promotes prostate tumorigenesisSkin toxicity caused by EGFR antagonists-an autoinflammatory condition triggered by deregulated IL-1 signaling?Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin.Immunological considerations of modern animal models of malignant primary brain tumors.Safety profile of new anticancer drugs.Two cases of psoriasis responding to erlotinib: time to revisiting inhibition of epidermal growth factor receptor in psoriasis therapy?.Panitumumab in metastatic colorectal cancer.Skin toxicity of targeted cancer agents: mechanisms and intervention.Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors.The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.The genomic landscape of human immune-mediated diseases.
P2860
Q26745689-51755B91-2CD3-402E-A251-9EA28AD5A72BQ26774605-2DE423BE-D1B4-4520-A2CB-0E120CBA4605Q27023344-EDC1DDBB-97D4-425F-B95E-D6A587F3CB03Q27908551-3FA8E051-6F69-46DC-942A-B7B1F496CF17Q28069454-9DFCB791-B6F0-460B-B56D-055302E397A3Q28084802-D2615288-A496-4909-82F7-D509060B27DEQ28245414-BFF1FB59-D95C-4227-909E-8055E8D28B79Q28554923-32C36A9C-0CF1-4C8A-BC82-56138AA85192Q28728031-ECC34001-023F-4B26-A130-17CD9361F50FQ31111797-E8EAFB67-842C-4EAC-8D39-553FFA934161Q33858156-C4A3E165-0FCB-43CE-90B6-1B228193317EQ33913781-B3D65083-05D6-4A34-9D06-2953B246E653Q34020597-D46A86E1-BAA2-48A9-B4AA-4EF11A2CD76FQ34567916-B93F5E96-8D6D-44F3-954D-B07BBE4E74D4Q34632791-886E073F-9B40-462C-AE4D-D18D4B3D0456Q35059625-CBD06174-79D7-4077-B9A8-889942A148A3Q35071059-6C076343-7514-4A8C-ABFE-7A1011DCAA93Q35086445-800F850B-25A2-455E-A7C2-B2B8ACECD51EQ35245080-59239A44-E1B4-404E-BC16-10C0043F3706Q35838744-687AFAD8-4780-4E49-B7F6-07BE61A66DD2Q35905805-46BF4272-E9A0-4FBB-BFE3-F21B370CB051Q36026706-C3FB34CB-A0C2-4E7F-BD65-ADA4B310AEACQ36088496-0301C379-3EB4-48BA-AC27-3D596CCE0807Q36176585-360770CC-211F-489B-8D5D-454C67C99C34Q36720696-0C44497C-F7C7-434D-BED5-57D567248B22Q37009956-4E8715B5-9B61-4CBE-A567-761F58A66C6CQ37138420-05039BC4-A845-43CB-A90D-04AB298D88B1Q37138534-26A098E2-8E27-43B5-8710-365E2D584242Q37264417-5C7ECDA3-09E1-44D4-8A7E-F4460973DC65Q37280601-E55E71A2-C914-477E-BAEE-67907BCC4CBDQ37361204-AE596012-4101-4D47-B599-532826207297Q37565269-143E32B0-E1B4-4128-9A48-0656053999FEQ37611109-1B4ECA10-03A6-4420-BD70-E3F3775DDACFQ37696502-7F4B4F0A-4AEE-4E95-A30B-3EC088736F52Q38055311-7E8A013E-18AF-429B-A825-DFB2DCFE9D80Q38117191-E95AB623-86AD-41AF-9D0B-861F98A8D25CQ38125504-8F4B2F24-043A-4187-BF82-076BF6117CF3Q38207484-FE385B6B-7F77-4B39-AEBE-049ACC1C4F84Q38207758-AC011C21-5CB1-4249-B97B-7FE95903479EQ38569875-F2185A4E-3BAE-41B8-9C7C-CC4B59C3AA3C
P2860
Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@ast
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@en
type
label
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@ast
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@en
prefLabel
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@ast
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@en
P2093
P2860
P1476
Blockade of the EGF receptor i ...... to enhanced skin inflammation.
@en
P2093
Francesca Mascia
Giampiero Girolomoni
Saveria Pastore
Valentina Mariani
P2860
P304
P356
10.1016/S0002-9440(10)63654-1
P407
P577
2003-07-01T00:00:00Z